# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-005682
Filing Date
2014-08-12
Accepted
2014-08-12 16:45:01
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0614_actinium.htm | 10-Q | 386391
2 | BY LAWS | f10q0614ex3i_actinium.htm | EX-3.1 | 91265
3 | CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNT | f10q0614ex31i_actinium.htm | EX-31.1 | 12945
4 | CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNT | f10q0614ex32i_actinium.htm | EX-32.1 | 5666
| Complete submission text file | 0001213900-14-005682.txt |  | 4807697

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | atnm-20140630.xml | EX-101.INS | 569433
6 | XBRL SCHEMA FILE | atnm-20140630.xsd | EX-101.SCH | 61975
7 | XBRL CALCULATION FILE | atnm-20140630_cal.xml | EX-101.CAL | 22721
8 | XBRL DEFINITION FILE | atnm-20140630_def.xml | EX-101.DEF | 228212
9 | XBRL LABEL FILE | atnm-20140630_lab.xml | EX-101.LAB | 497804
10 | XBRL PRESENTATION FILE | atnm-20140630_pre.xml | EX-101.PRE | 323091

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 141034499
SIC: 6770 Blank Checks